- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Strides Pharma Science Limited — Important, 27-06-2026: Sale or disposal
27-06-2026 | 03:58 pm
27-06-2026 | 03:58 pm
Strides Pharma is divesting a majority stake in its subsidiary, Pivot Path, to a consortium led by Ascent Capital for ~Rs. 100 Cr. Ascent Capital will also infuse ~Rs. 50 Cr into Pivot Path for growth. This reclassifies Pivot Path as an associate.
No comments yet. Be the first to comment!